Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
Standard BioTools is committed to empowering the cancer immunotherapy community with research tools to interrogate the tumor microenvironment with unprecedented resolution. Whether you seek to target new biomarkers or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Standard BioTools can help you reach your next research breakthrough. Engage with us at www.standardbiotools.com
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. We make the proteome actionable to empower research, drug development, and clinical decision-making with our versatile portfolio of mass spectrometry-based proteomics research services, software, and kits. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types.
